Manchanda, Ranjit; Sun, Li; Patel, Shreeya; Evans, Olivia; Wilschut, Janneke; Lopes, Ana Carolina De Freitas; Gaba, Faiza; Brentnall, Adam; Duffy, Stephen; Soarez, Patricia Coelho De 
Subjects: NEOPLASIAS MAMÁRIAS, NEOPLASIAS OVARIANAS, MUTAÇÃO GENÉTICA, PREVENÇÃO DE DOENÇAS, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANCHANDA, Ranjit et al. Economic evaluation of population-BasedBRCA1/BRCA2Mutation testing across multiple countries and health systems. Cancers, v. 12, n. 7, 2020Tradução . . Disponível em: https://doi.org/10.3390/cancers12071929. Acesso em: 18 nov. 2024.APA
Manchanda, R., Sun, L., Patel, S., Evans, O., Wilschut, J., Lopes, A. C. D. F., et al. (2020). Economic evaluation of population-BasedBRCA1/BRCA2Mutation testing across multiple countries and health systems. Cancers, 12( 7). doi:10.3390/cancers12071929NLM
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, Lopes ACDF, Gaba F, Brentnall A, Duffy S, Soarez PCD. Economic evaluation of population-BasedBRCA1/BRCA2Mutation testing across multiple countries and health systems [Internet]. Cancers. 2020 ; 12( 7):[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers12071929Vancouver
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, Lopes ACDF, Gaba F, Brentnall A, Duffy S, Soarez PCD. Economic evaluation of population-BasedBRCA1/BRCA2Mutation testing across multiple countries and health systems [Internet]. Cancers. 2020 ; 12( 7):[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers12071929
